Rathbones Group PLC Abiomed Inc Transaction History

Rathbones Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $571 - $710	-2 Reduced 0.04%	5,400 $1.72 Million
Q2 2020 Aug 07, 2020	SELL	$141.4 - $257.09 $42,420 - $77,126	-300 Reduced 5.26%	5,402 $1.31 Million
Q3 2019 Nov 13, 2019	BUY	$175.89 - $279.23 $351 - $558	2 Added 0.04%	5,702 $1.01 Million
Q2 2019 Aug 12, 2019	SELL	$250.96 - $284.94 $32.5 Million - $36.9 Million	-129,500 Reduced 95.78%	5,700 $1.49 Million
Q4 2017 Jan 24, 2018	SELL	$168.78 - $199.74 $33,756 - $39,948	-200 Reduced 0.15%	135,200 $25.3 Million
Q3 2017 Oct 24, 2017	BUY	$145.39 - $168.6 $19.7 Million - $22.8 Million	135,400	135,400 $22.8 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

Stay updated on Rathbones Group PLC with notifications on news.